Phytohealth Corp (TW:4108) — Market Cap & Net Worth
Market Cap & Net Worth: Phytohealth Corp (4108)
Phytohealth Corp (TW:4108) has a market capitalization of $70.71 Million (NT$2.24 Billion) as of September 17, 2026. Listed on the TW stock exchange, this Taiwan-based company holds position #20649 globally and #1216 in its home market, demonstrating a -0.88% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Phytohealth Corp's stock price NT$11.30 by its total outstanding shares 198619000 (198.62 Million). Also see Phytohealth Corp total assets for a full breakdown of the balance sheet.
Phytohealth Corp Market Cap History: 2015 to 2026
Phytohealth Corp's market capitalization history from 2015 to 2026. Data shows change from $169.02 Million to $70.71 Million (-8.30% CAGR). Also see cash efficiency ratio of Phytohealth Corp for how efficiently the company converts equity into cash flow.
Phytohealth Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Phytohealth Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check current stock price of Phytohealth Corp for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.63x
Phytohealth Corp's market cap is 0.63 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $185.40 Million | $25.02 Million | -$194.52 Million | 7.41x | N/A |
| 2017 | $141.10 Million | $54.00 Million | -$206.35 Million | 2.61x | N/A |
| 2018 | $109.85 Million | $107.48 Million | -$182.48 Million | 1.02x | N/A |
| 2019 | $109.24 Million | $95.48 Million | -$170.93 Million | 1.14x | N/A |
| 2020 | $153.54 Million | $91.81 Million | -$118.66 Million | 1.67x | N/A |
| 2021 | $145.80 Million | $168.94 Million | -$78.02 Million | 0.86x | N/A |
| 2022 | $119.52 Million | $135.47 Million | -$115.03 Million | 0.88x | N/A |
| 2023 | $135.79 Million | $162.49 Million | -$47.12 Million | 0.84x | N/A |
| 2024 | $105.13 Million | $153.56 Million | -$73.50 Million | 0.68x | N/A |
| 2025 | $84.48 Million | $134.58 Million | -$58.20 Million | 0.63x | N/A |
Competitor Companies of 4108 by Market Capitalization
Companies near Phytohealth Corp in the global market cap rankings as of September 17, 2026. Review how tangible is Phytohealth Corp's equity to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Phytohealth Corp by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #631 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #636 globally with a market cap of $43.34 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #672 globally with a market cap of $40.69 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #631 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.00 |
| #636 | GALDERMA GROUP AG | NYSE:GALDY | $43.34 Billion | $37.18 |
| #672 | Haleon plc | NYSE:HLN | $40.69 Billion | $9.24 |
Phytohealth Corp Historical Marketcap From 2015 to 2026
Between 2015 and today, Phytohealth Corp's market cap moved from $169.02 Million to $ 70.71 Million, with a yearly change of -8.30%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$70.71 Million | -16.30% |
| 2025 | NT$84.48 Million | -19.64% |
| 2024 | NT$105.13 Million | -22.58% |
| 2023 | NT$135.79 Million | +13.61% |
| 2022 | NT$119.52 Million | -18.03% |
| 2021 | NT$145.80 Million | -5.04% |
| 2020 | NT$153.54 Million | +40.55% |
| 2019 | NT$109.24 Million | -0.55% |
| 2018 | NT$109.85 Million | -22.15% |
| 2017 | NT$141.10 Million | -23.89% |
| 2016 | NT$185.40 Million | +9.69% |
| 2015 | NT$169.02 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Phytohealth Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $70.71 Million USD |
| MoneyControl | $70.71 Million USD |
| MarketWatch | $70.71 Million USD |
| marketcap.company | $70.71 Million USD |
| Reuters | $70.71 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Phytohealth Corp
PhytoHealth Corporation researches, develops, manufactures, and sells medicines, cosmetics, Class B medicines, complementary foods, and other related products in Taiwan. It operates in three segments: Medicines and Health Food, Medical Diagnosis, and Precision Medical Equipment and Instruments. The Medicines and Health Food segment manufactures and sells Chinese medicine materials and new drugs. … Read more